Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 71.9;liver: 122.7;tongue: 111.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.4"	"Group enriched"	"Detected in some"	4	"A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	60.4	4.0	1.8	2.0	3.3	0.0	71.9	2.5	2.1	1.3	2.9	1.0	1.2	5.5	1.0	3.0	17.4	1.5	19.4	9.3	1.7	2.3	4.8	122.7	5.9	1.1	4.7	0.9	1.9	2.4	0.0	1.8	0.1	4.2	8.1	2.4	2.0	12.0	2.4	19.8	4.2	2.4	4.4	3.9	0.6	26.2	2.3	2.6	0.1	4.2	111.8	5.5	25.3	11.9	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	130.6	0.1	13.8	162.1	5.6	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.7	0.9	0.6	3.6	0.0	0.6	0.0	0.0	0.0	0.0	36.8	243.7	0.3	0.0	0.0	14.5	8.2	0.6	0.6	0.0	0.0	0.0	5.0	0.0	1.3	0.2	0.0	0.0	0.0	168.2	0.0	0.0	0.0	2.1	1.2	74.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.1	4.8	0.0	0.0	0.0	0.0	1.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.8	3.3	2.5	2.1	1.7	2.3	4.7	0.9	4.2	2.6	11.9	3.2	0.0	3.2	10.5	1.8	3.7	135.0	18.7	19.4	0.0	0.0	0.0	0.0	12.3	18.3	8.7	9.3	0.0	93.5	0.1	15.0	4.5	0.0	341.7	0.1	3.2	1.7	12.3	13.7	5.6	73.4	1.1	8.5	1.0	2.8	33.8	140.7	7.0	73.9	2.6	2.6	0.0	7.6	0.3	0.3	11.8	0.0	1.3	7.4	79.1
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	115.0	0.0	33.6	66.2	23.8	0.0	0.0	1.6	0.0	0.1	3.4	1.9	0.0	6.2	1.5	3.4	0.9	0.1	2.3	0.0	0.2	0.0	0.2	35.6	48.3	0.3	0.0	0.0	13.2	4.7	1.5	0.0	1.9	2.2	0.2	0.7	0.0	3.0	0.2	0.7	0.1	0.0	226.4	0.3	0.2	0.7	3.4	11.3	45.4	0.0	0.2	16.5	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.3	6.9	0.2	0.0	0.0	0.0	3.8	4.5	0.3	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2	41.7	4.0	1.5	1.1	10.6	1.7	3.6	0.0	88.3	61.4	34.9	0.0	0.1	36.5	85.3	2.9	61.2	261.7	0.0	644.1	0.0	13.8	0.7	5.7	0.0	1.6	1.6	18.4	0.0	0.0	2.1	72.5	19.0	20.3	5.4	31.0	121.7	362.8	121.1	100.4	434.1	3.6	25.8	8.0	0.3	0.7	9.4	0.0	0.0	103.0	27.3
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138117986	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 103.2"	"Group enriched"	"Detected in some"	41	"Early spermatids: 50.2;Hepatocytes: 96.2;Late spermatids: 85.4"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 16.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	2.7	0.5	0.7	0.7	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.3	16.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.3	0.3	0.2	0.2	0.3	0.3	2.7	0.5	0.6	0.4	0.4	0.3	0.6	0.4	0.4	0.3	1.1	0.5	0.7	1.8	0.7	0.5	0.5	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	96.2	0.4	0.0	0.0	1.3	1.9	85.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.1
BCO2	"B-DIOX-II, BCDO2, FLJ34464"	ENSG00000197580	"Beta-carotene oxygenase 2"	Q9BYV7	11	112175467-112224699	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 28.9;liver: 44.0"	"Cell type enhanced"	"Detected in many"	17	"Cone photoreceptor cells: 386.8;Horizontal cells: 127.1;Rod photoreceptor cells: 238.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.6;HHSteC: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA061542	Supported					NA	NA					"HPA061542: "	"unprognostic (2.92e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-1)"	2.3	14.7	4.0	0.9	6.8	0.8	1.3	1.9	4.6	1.2	1.5	5.9	0.3	1.1	2.0	2.8	2.1	9.5	6.0	28.9	3.5	3.9	1.6	44.0	1.8	0.9	10.5	2.6	1.5	1.3	0.8	16.3	3.9	9.5	1.3	1.1	12.4	1.1	1.5	17.3	1.5	1.6	4.4	11.0	1.0	1.1	2.4	9.8	0.0	1.9	1.0	1.3	1.3	2.7	0.3	0.5	0.3	0.6	2.8	0.2	0.0	0.1	1.3	0.6	0.8	0.5	0.6	0.0	0.4	0.3	0.1	0.7	0.0	7.6	0.5	0.6	0.9	0.7	1.6	0.0	0.3	0.5	0.1	0.2	1.0	0.7	0.5	16.4	0.5	0.3	0.1	3.1	0.2	0.5	1.5	0.1	0.1	0.2	0.4	0.1	0.1	0.6	1.6	0.1	0.8	0.2	0.4	0.2	0.2	0.3	0.3	0.6	0.3	0.6	0.3	0.0	0.2	0.4	0.3	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.3	0.0	3.4	0.4	0.1	0.6	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.5	0.2	0.0	0.0	0.3	2.8	0.2	0.2	0.0	0.0	4.0	6.8	1.9	4.6	3.5	3.9	10.5	2.6	9.5	9.8	3.0	1.9	3.7	15.0	3.0	12.6	42.5	38.2	53.5	9.1	5.2	386.8	0.2	0.0	2.8	2.2	4.0	7.0	0.0	1.8	0.3	5.6	7.3	5.7	78.4	0.9	127.1	7.9	15.4	3.0	1.7	3.7	2.6	1.7	4.6	0.7	13.3	1.2	3.5	3.5	1.0	238.0	0.0	4.6	5.4	2.4	2.8	0.6	3.9	2.9	8.9
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837533	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 425.4"	"Cell type enhanced"	"Detected in some"	17	"Distal tubular cells: 18.3;Early spermatids: 40.8;Proximal tubular cells: 39.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Region enriched"	"Detected in single"	103	"basal ganglia: 19.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 8.0;SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced				"Intracellular and membrane"	NA	NA					"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.0	425.4	0.0	0.1	19.7	0.0	0.0	0.1	0.1	0.1	0.0	78.5	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.4	1.7	0.1	0.0	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	82.3	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	3.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	19.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.1	0.6	0.6	0.0	0.0	0.0	1.8	0.0	0.3	18.3	0.0	40.8	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	3.2	0.1	1.6	0.0	0.0	0.0	8.3	1.7	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.0	39.5	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1
HSD17B1	"EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1"	ENSG00000108786	"Hydroxysteroid 17-beta dehydrogenase 1"	P14061	17	42549214-42555213	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 217.6"	"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 1251.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	8	"BEWO: 89.7"	"Low region specificity"	"Detected in single"							"HPA021032, HPA065296"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA021032: AB_1844345, HPA065296: AB_2685457"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.88e-5)"	"unprognostic (2.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.09e-1)"	"unprognostic (4.98e-1)"	"unprognostic (1.32e-2)"	2.8	1.5	2.0	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2.0	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6.0	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.8	0.9	4.6	0.6	0.1	89.7	1.2	0.0	0.0	0.0	1.0	0.9	0.0	1.2	0.0	1.0	2.6	0.1	0.7	0.0	2.4	2.8	1.2	1.1	1.5	0.2	1.0	1.4	0.2	2.6	0.1	0.5	1.5	0.0	1.3	1.7	0.4	0.0	1.6	1.3	1.1	0.4	0.6	0.8	1.3	1.1	0.8	0.1	1.4	1.3	1.8	0.7	9.1	1.4	1.0	11.0	0.8	1.4	1.4	1.8	1.0	0.8	2.6	1.5	0.6	0.6	0.9	1.1	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6.0	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2.0	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3	0.0	2.1	0.5	6.3	2.7	8.7	2.4	2.5	4.0	2.3	5.2	11.8	250.4	19.9	1.5	1.0	4.1	3.2	0.0	4.9	23.6	3.4	13.0	2.3	5.6	26.4	9.5	4.1	4.9	0.8	1.7	1.7	0.5	1.7	1.0	2.4	9.0	2.0	2.5	3.2	10.5	8.2	0.0	2.8	0.7	2.6	6.5	1251.0	1.3	1.9	8.4
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 489.8;Paneth cells: 501.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.5"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.7	5.2	13.1	16.1	22.2	7.4	5.8	9.1	3.8	7.0	8.9	68.5	0.0	11.2	5.9	3.6	0.2	15.2	1.2	4.2	16.9	3.2	14.7	5.9	30.0	9.1	26.2	27.5	15.7	0.4	5.2	1.8	12.1	7.3	6.4	15.3	7.6	7.0	0.4	5.3	32.1	8.9	33.3	1.8	14.7	4.8	17.3	10.5	16.4	1.7	16.7	11.4	0.3	19.5	7.0	0.0	25.6	6.1	2.6	11.8	10.5	3.0	3.7	1.5	1.6	4.9	18.6	17.8	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6	291.8	133.2	72.8	64.6	24.8	1.2	4.4	310.8	75.0	111.5	41.8	2.0	27.4	21.6	38.6	0.9	71.4	489.8	0.0	51.8	45.8	75.4	36.7	98.1	303.2	118.3	17.5	90.0	101.9	213.8	0.9	96.4	169.0	64.1	36.1	155.1	34.2	52.9	501.0	55.9	148.1	3.9	71.1	54.2	2.6	13.1	18.7	12.5	110.7	226.2	80.0
HSD17B12	"KAR, SDR12C1"	ENSG00000149084	"Hydroxysteroid 17-beta dehydrogenase 12"	Q53GQ0	11	43680558-43856617	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016427	Approved					NA	NA		200000			"HPA016427: AB_1844347"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.16e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (2.10e-8)"	"unprognostic (6.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	27.2	32.6	33.5	16.6	31.9	10.5	30.4	12.8	33.1	26.3	30.7	31.4	29.3	32.0	22.3	25.3	24.3	20.1	28.0	36.9	30.9	31.1	42.9	59.8	25.8	19.9	38.5	21.4	22.4	26.4	66.6	29.4	19.4	45.7	26.4	29.4	26.6	25.3	22.9	16.1	18.2	30.8	23.3	44.9	23.5	25.6	17.6	24.4	15.2	32.4	32.5	17.5	19.4	18.6	12.8	18.7	9.8	12.7	13.5	15.0	9.6	9.0	14.8	16.5	16.7	55.3	52.6	10.8	23.4	23.1	16.3	17.8	17.9	19.1	22.7	16.6	21.0	27.0	35.7	11.5	29.5	20.2	4.2	21.3	10.5	8.3	15.6	28.1	32.5	30.1	32.3	22.7	16.4	46.8	20.8	22.5	14.3	9.9	37.9	14.0	5.2	8.6	14.5	30.2	11.4	10.8	14.6	24.5	25.6	31.1	22.4	6.0	13.6	31.3	26.4	22.8	16.2	18.9	26.2	21.5	17.6	6.9	45.7	27.3	19.5	24.5	13.6	19.1	5.8	13.2	6.1	12.2	5.5	11.0	12.7	11.7	11.0	8.8	9.2	18.7	12.8	15.0	12.9	9.8	13.5	6.5	15.1	5.0	9.6	33.5	31.9	12.8	30.8	30.9	31.1	38.5	21.4	45.7	24.4	59.6	94.5	60.7	41.7	28.2	71.5	81.5	76.5	89.7	64.8	48.8	72.6	50.4	23.2	87.7	47.4	65.0	71.5	23.3	72.4	37.6	41.7	54.4	152.4	109.0	55.3	114.4	132.6	70.0	43.0	14.4	31.7	49.6	37.1	32.5	68.5	118.3	65.6	45.6	53.4	39.7	63.0	77.6	48.4	11.4	11.5	40.0	62.6	27.4	93.1	38.3
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6"	"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	22.4	0.0	0.0	4.1	0.6	0.0	4.5	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	17.8	0.1	0.1	0.1	0.0	1.2	0.0	10.7	0.2	0.3	0.0	0.0	0.1	3.3	0.0	0.0	0.3	0.1	32.8	8.1	0.0	0.0	0.4	0.4	36.8	0.2	0.6	0.0	1.0	0.1	0.0	0.0	0.0	20.6	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	3.0	3.8	0.0	2.7	0.3	0.1	0.4	137.6	6.7	2.3	0.0	0.0	2.1	0.0	47.5	0.1	0.2	250.1	0.0	5.5	1.5	3.1	1.8	0.0	98.5	3.0	0.0	2.9	3.1	2.4	0.8	0.0	0.0	1.7	0.0	19.3	42.0	13.6	199.9	0.0	1.0	0.6	0.0	0.3	0.0	0.0	1.0	5.4	0.0	33.8	10.0
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease mutation, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 41.9"	"Cell type enriched"	"Detected in some"	8	"Leydig cells: 100.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	0.5	0.4	1.0	0.5	1.0	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1.0	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.0	1.0	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.4	0.3	0.0	0.4	0.0	0.2	0.1	0.0	1.6	0.0	0.0	1.7	0.0	0.0	7.8	100.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	12.0	0.0	0.2	0.0	0.5	0.3	1.9	0.3	0.1	0.0	0.2	0.0
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 241.2"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 1569.2"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.8;U-266/84: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2.0	2.6	1.1	0.3	0.2	0.0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1.0	6.2	0.8	3.2	0.8	0.0	13.3	0.0	0.3	9.9	2.3	2.0	2.0	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2.0	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1.0	6.5	2.0	3.2	1.0	0.5	1.1	1.6	5.3	0.9	0.3	1.0	0.5	0.5	0.0	9.0	0.9	11.8	0.8	2.1	4.6	1.0	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2.0	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0.0	0.2	0.1	3.0	0.6	3.4	2.0	2.5	2.4	0.6	1.1	3.3	2.2	0.0	0.1	1.3	2.0	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2.0	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17.0	0.0	0.0	1.3	0.0	0.0	2.5	0.4	0.0	23.3	0.0	2.4	4.8	9.9	0.0	1569.2	0.3	0.0	0.0	31.3	41.1	1.5	11.5	0.1	0.0	1.8	0.3	1.0	0.1	0.0	1.4	0.0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9
HSD17B7	"PRAP, SDR37C1"	ENSG00000132196	"Hydroxysteroid 17-beta dehydrogenase 7"	P56937	1	162790702-162812817	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.3;liver: 16.8"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 58.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047496	Approved					NA	NA					"HPA047496: AB_2680068"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.47e-5)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.17e-2)"	1.9	9.2	1.4	2.0	1.0	0.7	4.3	1.4	1.9	2.8	2.9			3.1	2.1	4.4	4.7	2.2	1.6	1.6	1.9	2.6	2.2	16.8	4.3	3.7	1.5		3.6	2.6	2.5	4.1	1.8		2.8	4.0		3.1	1.3	2.0	3.6	3.1	1.8	3.2	2.9	2.9	0.6			2.8		3.9	2.2	2.8	12.5	9.6	15.8	7.4	7.0	16.3	10.5	6.3	6.5	17.3	7.7	10.0	10.8	11.3	2.6	8.3	5.1	10.2	9.0	20.6	15.3	5.9	2.2	31.0	10.3	15.7	22.2	5.3	6.7	8.4	3.9	4.9	14.1	8.3	6.9	6.9	6.5	12.4	19.6	6.4	4.0	8.4	10.7	7.3	10.6	4.3	4.5	8.9	7.4	11.0	12.3	8.1	5.0	10.4	9.8	18.0	10.2	14.8	7.7	4.1	4.0	3.9	15.6	6.5	8.8	4.9	2.3	5.6	3.5	5.0	6.5	6.4	15.2	3.7	0.6	5.7	15.8	6.0	11.2	13.9	6.1	14.6	12.5	10.5	13.4	6.5	10.9	13.0	13.1	5.0	7.0	7.4	9.6	16.3	10.5											0.0	23.8	19.9	22.2	9.7	23.0	2.0	15.3	18.7	15.9	10.4	58.9	14.2	3.3	11.4	1.7	11.7	10.9	0.0	23.7	12.6	13.1	20.2	4.7	22.5	11.6	11.1	5.8	7.4	2.8	1.0	6.4	13.0	16.9	10.0	7.9	14.1	12.6	14.0	6.7	9.3	42.9	0.0	11.3	2.1	5.4	11.0	16.0	20.2	8.5	11.5
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 106.1;Proximal tubular cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		52000			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	1.0	1.3	0.3	0.6	0.4	0.1	0.7	0.0	0.0	1.5	2.5	7.0	2.0	0.1	0.3	4.2	1.0	3.2	0.1	1.2	1.2	0.3	2.0	3.8	3.0	0.0	0.5	0.7	4.3	0.0	7.4	0.0	0.3	2.5	0.1	6.8	0.6	2.3	5.2	0.1	0.3	3.3	0.9	3.0	0.1	14.8	4.1	0.1	2.0	1.1	0.4	5.6	1.3	0.7	9.6	0.2	0.1	0.2	1.2	0.0	0.0	14.6	7.0	2.6	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4	17.9	16.3	6.7	21.5	26.4	10.3	24.3	38.2	26.8	14.8	21.0	5.9	25.7	106.1	24.6	5.1	8.5	30.9	23.3	28.3	10.1	10.0	13.7	6.9	60.4	14.9	1.6	17.2	6.7	8.9	11.1	6.9	10.0	47.2	10.0	23.7	28.7	19.1	21.0	5.6	106.8	11.8	0.0	5.9	7.5	5.5	32.5	14.5	14.0	43.6	21.3
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
SRD5A1		ENSG00000145545	"Steroid 5 alpha-reductase 1"	P18405	5	6633343-6674386	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.4"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 75.4;monocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA051402	Approved					NA	NA					"HPA051402: AB_2681470"	"unprognostic (1.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.30e-3)"	"prognostic unfavorable (8.73e-6)"	"unprognostic (9.38e-3)"	"unprognostic (8.90e-2)"	"unprognostic (3.78e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.47e-2)"	2.4	3.3	7.7	2.9	8.2	3.2	14.8	9.2	11.8	5.6	5.2	5.3	0.7	5.7	3.1	4.6	24.2	2.9	4.0	1.9	9.3	7.5	6.4	42.4	3.0	3.5	6.2	5.5	4.1	4.3	3.0	1.9	2.1	13.4	2.6	3.6	2.4	5.0	2.1	2.2	17.5	10.4	2.6	3.1	2.9	3.9	2.7	2.9	3.3	2.4	15.3	12.1	2.6	10.1	1.9	3.7	7.0	3.3	1.3	1.3	1.3	5.6	5.5	7.4	6.3	7.1	7.0	3.4	5.4	4.2	5.4	3.4	5.5	5.0	6.8	9.0	7.9	8.8	9.1	6.0	3.6	5.8	4.2	2.6	2.1	13.9	3.4	3.3	3.0	1.8	5.1	10.4	3.8	3.0	4.0	2.6	2.7	3.6	6.3	6.9	6.6	1.4	3.5	4.7	3.7	4.4	4.7	5.7	2.0	7.2	5.2	14.0	6.3	16.6	7.4	5.1	7.7	3.0	0.9	5.5	8.2	4.1	13.3	6.8	3.4	4.5	2.4	6.8	3.6	7.4	7.0	3.3	1.4	1.0	2.4	0.7	1.7	1.0	1.3	3.7	1.9	0.9	1.0	2.0	1.3	2.6	1.8	1.1	1.3	7.7	8.2	9.2	11.8	9.3	7.5	6.2	5.5	13.4	2.9	3.0	2.4	8.2	5.5	16.5	4.4	2.4	5.1	8.1	2.3	5.2	3.9	0.7	6.6	9.1	7.8	3.1	7.8	0.0	4.1	6.1	3.7	6.5	1.1	75.4	12.0	6.4	2.4	4.3	19.6	1.9	3.1	7.9	6.8	55.1	5.6	3.5	6.5	8.7	7.4	19.5	3.7	0.0	4.2	2.7	2.6	26.6	0.7	4.4	11.7	9.6
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31581067	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;liver: 30.9;prostate: 28.4"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 13.4;Early spermatids: 70.2;Hepatocytes: 14.7;Late spermatids: 41.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BJ hTERT+: 2.9;RT4: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	10.1	0.0	0.2	17.9	0.0	10.4	0.0	0.0	0.0		0.0	30.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0											0.0	0.0	0.0	3.1	0.0	0.0	0.4	2.5	13.4	1.2	0.0	0.0	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	14.7	0.0	0.0	0.0	0.0	0.0	41.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.2	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	4.7
SRD5A3	"FLJ13352, SRD5A2L, SRD5A2L1"	ENSG00000128039	"Steroid 5 alpha-reductase 3"	Q9H8P0	4	55346109-55373096	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Cataract, Congenital disorder of glycosylation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 42.6"	"Low region specificity"	"Detected in all"							HPA027006	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA027006: AB_1857469"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-2)"	"prognostic favorable (9.39e-4)"	"unprognostic (1.50e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (9.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.85e-10)"	"unprognostic (4.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.52e-2)"	13.8	12.2	11.5	5.9	13.4	6.6	17.8	7.3	18.3	22.9	11.3	20.3	3.5	6.9	13.8	9.6	24.4	5.9	22.6	10.5	13.2	10.7	12.3	15.0	12.4	10.1	15.5	12.0	3.5	26.8	14.0	7.0	8.8	13.6	8.9	10.9	6.8	16.3	6.6	5.8	15.6	8.3	6.2	22.1	6.9	13.8	4.0	15.3	10.0	7.6	9.9	12.1	12.1	12.1	5.9	28.4	10.3	25.2	3.6	9.2	10.3	4.8	3.2	5.8	5.5	19.5	12.5	2.9	5.3	6.2	2.2	3.6	3.2	10.1	11.5	6.0	8.3	6.2	3.8	4.1	4.9	2.8	3.3	7.3	6.3	3.6	8.6	5.2	11.6	3.5	11.4	9.1	3.8	3.5	4.8	9.0	21.5	10.7	25.8	12.6	6.3	17.0	5.1	7.3	27.6	4.3	5.5	1.8	6.5	7.4	5.2	9.0	5.0	5.6	42.6	3.8	6.0	5.2	10.2	4.4	14.2	2.6	1.0	4.0	13.8	7.6	4.2	18.0	16.0	13.8	10.3	16.5	4.9	7.9	25.1	9.2	5.9	6.0	7.4	14.1	5.2	5.3	7.1	0.8	3.6	25.2	28.4	5.8	10.3	11.5	13.4	7.3	18.3	13.2	10.7	15.5	12.0	13.6	15.3	8.9	15.7	3.0	9.5	12.0	4.6	4.6	45.9	12.0	12.5	5.2	3.9	22.7	3.3	67.0	2.0	14.3	8.4	0.0	92.9	88.2	17.0	22.1	13.9	17.1	62.0	9.5	11.5	17.8	20.9	0.0	1.7	27.9	23.6	24.4	19.3	18.6	133.4	5.8	5.3	12.2	3.8	12.9	9.5	2.1	18.8	26.0	6.3	4.9	20.9	49.7
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0"									HPA002904	Enhanced					NA	NA					"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.1	1.3	2.8	0.9	20.3	10.5	15.0	8.4	3.0	2.3	2.1	7.4	3.9	7.7	1.6	6.1	1.8	1.0	1.6	1.4	2.3	0.6	3.2	0.4	4.7	2.1	1.1	1.1	4.4	3.4	0.2	1.4	0.8	1.5	3.4	0.6	0.4	8.1	6.0	0.9	0.6	1.0	1.0	0.0	1.9	1.1	1.6	25.9	5.7	6.0	2.0	1.7	1.7	3.0	0.9	4.8	1.3	0.4	6.0	9.1	0.5	11.6	1.3	43.0	0.0	18.0	2.1	0.9	2.4	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3	11.9	2.1	1.5	1.7	0.8	3.1	5.0	2.5	0.0	1.2	1.8	0.0	34.3	0.0	6.9	0.1	4.3	4.1	0.0	17.1	18.7	4.1	7.6	6.9	7.4	6.6	1.6	3.5	2.5	5.9	0.0	2.6	2.7	1.7	2.8	2.3	3.1	8.7	7.4	6.3	1.4	0.8	0.0	4.7	0.0	1.4	0.9	78.6	0.0	2.2	7.4
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 47.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4"									"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	38.0	0.0	0.0	17.2	14.3	0.0	0.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1	0.0	0.0	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.2	0.1	0.0	0.0	47.0	0.2	0.0	0.0	1.8	1.0	0.0	0.3	0.0	1.7	0.0	0.2	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.3	0.0	0.0	0.1
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA041724, HPA043539, HPA076510"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	4.5	5.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	27.6	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.9	0.0	0.2	0.0	44.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.3	0.1	0.0	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	17.9	0.3	0.0	28.4	21.4	0.0	0.6	2.5	4.0	13.6	8.7	0.0	2.8	0.0	11.1	0.0	0.3	8.6	0.0	1.0	2.7	2.0	53.7	0.0	0.0	0.6	0.0	4.6	0.0	0.0	0.2	0.3	0.2	11.8	0.0	7.1	1.2	10.8	7.0	0.0	0.8	0.6	0.0	2.8	0.2	7.5	120.1	1.6	0.0	2.6	113.8
